Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v3-EN
Language English English
Date Updated 2017-07-27 2017-07-11
Drug Identification Number 02182777 02182777
Brand name METHOTREXATE INJECTION USP METHOTREXATE INJECTION USP
Common or Proper name METHOTREXATE METHOTREXATE
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients METHOTREXATE METHOTREXATE
Strength(s) 25MG 25MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRA-ARTERIAL INTRAMUSCULAR INTRAVENOUS INTRA-ARTERIAL INTRAMUSCULAR INTRAVENOUS
Packaging size 5x2mL VIAL/AMPOULE VIAL/AMPOULE
ATC code L01BA L01BA
ATC description ANTIMETABOLITES ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-07-10 2017-07-10
Estimated end date 2017-10-16 2017-07-24
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments Product under allocation. Please note that the following formats are currently available: DIN Product name Product Description Package size 2182777 METHOTREXATE INJECTION USP Solution for Injection, 25 mg/mL, Multidose Vial ONCO-TAINTM vial, 1 x 20 mL 2182955 METHOTREXATE INJECTION USP Solution for Injection Single-use, 25 mg/mL vial, 5 x 2 mL 2182971 METHOTREXATE INJECTION USP Solution for Injection Single-use, 25 mg/mL ONCO-TAINTM vial, 1 x 20 mL 2422166 METHOTREXATE INJECTION USP Solution for Injection, 25 mg/mL *Syringe, 1 x 0.3 mL 2422174 METHOTREXATE INJECTION USP Solution for Injection, 25 mg/mL *Syringe, 1 x 0.4 mL 2422182 METHOTREXATE INJECTION USP Solution for Injection, 25 mg/mL *Syringe, 1 x 0.6 mL 2422190 METHOTREXATE INJECTION USP Solution for Injection, 25 mg/mL *Syringe, 1 x 0.8 mL 2422204 METHOTREXATE INJECTION USP Solution for Injection, 25 mg/mL *Syringe, 1 x 1 mL Product under allocation. Please note that the following formats are currently available: DIN Product name Product Description Package size 2182777 METHOTREXATE INJECTION USP Solution for Injection, 25 mg/mL, Multidose Vial ONCO-TAINTM vial, 1 x 20 mL 2182955 METHOTREXATE INJECTION USP Solution for Injection Single-use, 25 mg/mL vial, 5 x 2 mL 2182971 METHOTREXATE INJECTION USP Solution for Injection Single-use, 25 mg/mL ONCO-TAINTM vial, 1 x 20 mL 2422166 METHOTREXATE INJECTION USP Solution for Injection, 25 mg/mL *Syringe, 1 x 0.3 mL 2422174 METHOTREXATE INJECTION USP Solution for Injection, 25 mg/mL *Syringe, 1 x 0.4 mL 2422182 METHOTREXATE INJECTION USP Solution for Injection, 25 mg/mL *Syringe, 1 x 0.6 mL 2422190 METHOTREXATE INJECTION USP Solution for Injection, 25 mg/mL *Syringe, 1 x 0.8 mL 2422204 METHOTREXATE INJECTION USP Solution for Injection, 25 mg/mL *Syringe, 1 x 1 mL
Health Canada comments